US Patent 11434280 Anti-C5 antibodies having improved pharmacokinetics
Patent 11434280 was granted and assigned to Alexion Pharmaceuticals, Inc. on September, 2022 by the United States Patent and Trademark Office.
Is a
Date Filed
January 23, 2020
Date of Patent
September 6, 2022
Patent Application Number
16750173
Patent Inventor Names
Douglas L. Sheridan
0
Yi Wang
0
Paul P. Tamburini
0
Bruce A. Andrien, Jr.
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11434280 Anti-C5 antibodies having improved pharmacokinetics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
